Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659458 · ClinicalTrials.gov registry record
Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
A clinical trial of Lung Cancer, Non-Small Cell and EGFR Exon 19 Deletion Mutation, sponsored by Our Lady of the Lake Hospital.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06659458 is a study of Lung Cancer, Non-Small Cell and EGFR Exon 19 Deletion Mutation that is actively recruiting participants, run by Our Lady of the Lake Hospital. The registered enrollment target is 20 participants, below the 329-participant average among 10 other Lung Cancer, Non-Small Cell trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06659458, a study of Lung Cancer, Non-Small Cell and EGFR Exon 19 Deletion Mutation, is actively recruiting participants, sponsored by Our Lady of the Lake Hospital.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the likelihood of an individual acquiring a cancer-linked mutation. The aim of this study is to collect blood from both those diagnosed with EGFR positive lung cancer and healthy individuals, evaluate their gene sequence surrounding the EGFR landscape and use the cancer positive and healthy sequences to validate the risk assessment model, which may one day be used to provide insight on susceptibility of getting EGFR positive lung cancer or potentially other cancer types.
Conditions Studied
Interventions
- OTHER blood draw
- OTHER Gene sequencing
Study Locations (1)
Louisiana
- Our Lady of the Lake Regional Medical Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06659458
The ClinicalTrials.gov registry entry for NCT06659458 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 10 other Lung Cancer, Non-Small Cell trials with a reported enrollment target (94% lower). The listed sponsor is Our Lady of the Lake Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer, Non-Small Cell appearing as the primary indexed condition, and to 2 interventions - of which blood draw is the first listed.
NCT06659458 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06659458 about?
NCT06659458 is a clinical study titled "Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients". EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the likelihood of an individual acquiring a cancer-linked mutation. The aim of this study is to collect bloo...
What is the current status of trial NCT06659458?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-01-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06659458 study?
This clinical trial studies the following conditions: Lung Cancer, Non-Small Cell, EGFR Exon 19 Deletion Mutation.
What interventions are being tested in trial NCT06659458?
The interventions under investigation include: blood draw (OTHER), Gene sequencing (OTHER).
Who is sponsoring clinical trial NCT06659458?
This trial is sponsored by Our Lady of the Lake Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06659458 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer, Non-Small Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
RECRUITING · Phase 1
-
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
ACTIVE NOT RECRUITING · Phase 3
-
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.